Research progress on the application of artificial intelligence technology in kidney disease

doi:10.3877/cma.j.issn.2095-3216.2021.06.009

Abstract

Abstract:

Artificial intelligence is playing an increasingly important role in many fields of medicine, which has greatly promoted the development of medical work. This review summarized the research on the successful application of artificial intelligence in the field of kidney disease, including disease monitoring, risk prediction, and clinical decision support. Simultaneously, suggestions and prospects were also put forward for the future development of artificial intelligence in the field of kidney disease, with a view to enabling it to make greater contributions to the clinical practice of kidney disease.

Key words: Machine learning, Artificial intelligence, Kidney disease, Neural network

Shuang Zhang, Shuxin Liu, Xiangwei Mu, Bowen Jiang, Cui Dong, Lianlian You. Research progress on the application of artificial intelligence technology in kidney disease[J]. Chinese Journal of Kidney Disease Investigation(Electronic Edition), 2021, 10(06): 342-346.

/ / Recommend

Add to citation manager EndNote|Ris|BibTeX

URL: https://zhsbyjdzzz.cma-cmc.com.cn/EN/10.3877/cma.j.issn.2095-3216.2021.06.009

https://zhsbyjdzzz.cma-cmc.com.cn/EN/Y2021/V10/I06/342

Figures/Tables 1

References 40

[1]	Fraser S, Roderick PJ. Kidney disease in the global burden of disease study 2017 [J]. Nat Rev Nephrol, 2019, 15(4): 193-194.
[2]	Yun CW, Lee SH. Potential and therapeutic efficacy of cell-based therapy using mesenchymal stem cells for acute/chronic kidney disease [J]. Int J Mol Sci, 2019, 20(7): 1619.
[3]	GBD Chronic Kidney Disease Collaboration. Global, regional, and national burden of chronic kidney disease, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017 [J]. Lancet, 2020, 395(10225): 709-733.
[4]	Wang F, Preininger A. AI in health: state of the art, challenges, and future directions [J]. Yearb Med Inform, 2019, 28(1): 16-26.
[5]	Goecks J, Jalili V, Heiser LM, et al. How machine learning will transform biomedicine [J]. Cell, 2020, 181(1): 92-101.
[6]	Miller DD, Brown EW. Artificial intelligence in medical practice: the question to the answer [J]. Am J Med, 2018, 131(2): 129-133.
[7]	Attia ZI, Noseworthy PA, Lopez-Jimenez F, et al. An artificial intelligence-enabled ECG algorithm for the identification of patients with atrial fibrillation during sinus rhythm: a retrospective analysis of outcome prediction [J]. Lancet, 2019, 394(10201): 861-867.
[8]	Sowah RA, Bampoe-Addo AA, Armoo SK, et al. Design and development of diabetes management system using machine learning [J]. Int J Telemed Appl, 2020, 2020: 8870141.
[9]	Bellemo V, Lim G, Rim TH, et al. Artificial intelligence screening for diabetic retinopathy: the real-world emerging application [J]. Curr Diab Rep, 2019, 19(9): 72.
[10]	Goodman S, Reid-Adam J. Immunoglobulin A nephropathy [J]. Pediatr Rev, 2019, 40(8): 439-441.
[11]	Rajasekaran A, Julian BA, Rizk DV. IgA nephropathy: an interesting autoimmune kidney disease [J]. Am J Med Sci, 2021, 361(2): 176-194.
[12]	Geddes CC, Fox JG, Allison ME, et al. An artificial neural network can select patients at high risk of developing progressive IgA nephropathy more accurately than experienced nephrologists [J]. Nephrol Dial Transplant, 1998, 13(1): 67-71.
[13]	Niel O, Boussard C, Bastard P. Artificial intelligence can predict GFR decline during the course of ADPKD [J]. Am J Kidney Dis, 2018, 71(6): 911-912.
[14]	Makino M, Yoshimoto R, Ono M, et al. Artificial intelligence predicts the progression of diabetic kidney disease using big data machine learning [J]. Sci Rep, 2019, 9(1): 11862.
[15]	Katsuki T, Ono M, Koseki A, et al. Risk prediction of diabetic nephropathy via interpretable feature extraction from EHR using convolutional autoencoder [J]. Stud Health Technol Inform, 2018, 247: 106-110.
[16]	Sabiu G, Podesta MA. Membranous nephropathy: it is time to go back to the future [J]. Nephron, 2021, 145(6): 721-727.
[17]	Ronco P, Debiec H. Pathophysiological advances in membranous nephropathy: time for a shift in patient's care [J]. Lancet, 2015, 385(9981): 1983-1992.
[18]	Tu T, Wei X, Yang Y, et al. Deep learning-based framework for the distinction of membranous nephropathy: a new approach through hyperspectral imagery [J]. BMC Nephrol, 2021, 22(1): 231.
[19]	Chan L, Beers K, Yau AA, et al. Natural language processing of electronic health records is superior to billing codes to identify symptom burden in hemodialysis patients [J]. Kidney Int, 2020, 97(2): 383-392.
[20]	Khavanin Zadeh M, Omrani Z, Najmi N. Prevalence and survival of hemodialysis vascular access in end-stage renal disease (ESRD) patients of Tehran, Iran [J]. Ann Iran Med, 2006, 3(8): 37-40.
[21]	Viecelli AK, Lok CE. Hemodialysis vascular access in the elderly-getting it right [J]. Kidney Int, 2019, 95(1): 38-49.
[22]	Kim DH, Park JI, Lee JP, et al. The effects of vascular access types on the survival and quality of life and depression in the incident hemodialysis patients [J]. Ren Fail, 2020, 42(1): 30-39.
[23]	Gerald B. Fistula first has resulted in an Increase in catheter use [J]. J Vasc Access, 2009，10(4): 284-285.
[24]	Rezapour M, Khavanin ZM, Sepehri MM. Implementation of predictive data mining techniques for identifying risk factors of early AVF failure in hemodialysis patients [J]. Comput Math Methods Med, 2013, 2013: 830745.
[25]	Ota K, Nishiura Y, Ishihara S, et al. Evaluation of hemodialysis arteriovenous bruit by deep learning [J]. Sensors (Basel), 2020, 20(17): 4852.
[26]	Tsur N, Menashe I, Haviv YS. Risk factors before dialysis predominate as mortality predictors in diabetic maintenance dialysis patients [J]. Sci Rep, 2019, 9(1): 10633.
[27]	Garcia-Montemayor V, Martin-Malo A, Barbieri C, et al. Predicting mortality in hemodialysis patients using machine learning analysis [J]. Clin Kidney J, 2021, 14(5): 1388-1395.
[28]	Radovi N, Prelevi V, Erceg M, et al. Machine learning approach in mortality rate prediction for hemodialysis patients [J]. Comput Methods Biomech Biomed Engin, 2021, Epub ahead of print.
[29]	Sedaghattalab M, Razazan M, Sadeghi H, et al. Effects of nasturtium officinale extract on antioxidant and biochemical parameters in hemodialysis patients: a randomized double-blind clinical trial [J]. Evid Based Complement Alternat Med, 2021, 2021: 1632957.
[30]	Mezzatesta S, Torino C, Meo P, et al. A machine learning-based approach for predicting the outbreak of cardiovascular diseases in patients on dialysis [J]. Comput Methods Programs Biomed, 2019, 177: 9-15.
[31]	Stuckey TD, Gammon RS, Goswami R, et al. Cardiac phase space tomography: a novel method of assessing coronary artery disease utilizing machine learning [J]. PLoS One, 2018, 13(8): e198603.
[32]	Cheng P, Waitman LR, Hu Y, et al. Predicting inpatient acute kidney injury over different time horizons: how early and accurate [J]. AMIA Annu Symp Proc, 2018, 2017: 565-574.
[33]	Ibrahim NE, McCarthy CP, Shrestha S, et al. A clinical, proteomics, and artificial intelligence-driven model to predict acute kidney injury in patients undergoing coronary angiography [J]. Clin Cardiol, 2019, 42(2): 292-298.
[34]	Chiu JS, Chong CF, Lin YF, et al. Applying an artificial neural network to predict total body water in hemodialysis patients [J]. Am J Nephrol, 2005, 25(5): 507-513.
[35]	Guo XY, Zhou W, Shi B, et al. An efficient multiple kernel support vector regression model for assessing dry weight of hemodialysis patients [J]. Curr Bioinform, 2021, 16(2): 284-293.
[36]	Shie AJ, Lo KH, Lin WT, et al. An integrated model using the Taguchi method and artificial neural network to improve artificial kidney solidification parameters [J]. Biomed Eng Online, 2019, 18(1): 78.
[37]	Ohara T, Ikeda H, Sugitani Y, et al. Artificial intelligence supported anemia control system (AISACS) to prevent anemia in maintenance hemodialysis patients [J]. Int J Med Sci, 2021, 18(8): 1831-1839.
[38]	Barbieri C, Molina M, Ponce P, et al. An international observational study suggests that artificial intelligence for clinical decision support optimizes anemia management in hemodialysis patients [J]. Kidney Int, 2016, 90(2): 422-429.
[39]	Kannan S, Morgan LA, Liang B, et al. Segmentation of glomeruli within trichrome images using deep learning [J]. Kidney Int Rep, 2019, 4(7): 955-962.
[40]	Kolachalama VB, Singh P, Lin CQ, et al. Association of pathological fibrosis with renal survival using deep neural networks [J]. Kidney Int Rep, 2018, 3(2): 464-475.

Please choose a citation manager

Content to export